ZNF709
gene geneOn this page
Also known as FLJ38281
Summary
ZNF709 (zinc finger protein 709, HGNC:20629) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 709 (Q8N972). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 163051 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 59 total
- MANE Select transcript:
NM_152601
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20629 |
| Approved symbol | ZNF709 |
| Name | zinc finger protein 709 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38281 |
| Ensembl gene | ENSG00000242852 |
| Ensembl biotype | protein_coding |
| Entrez | 163051 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000397732, ENST00000455490, ENST00000493776, ENST00000926406, ENST00000966691
RefSeq mRNA: 1 — MANE Select: NM_152601
NM_152601
CCDS: CCDS42504
Canonical transcript exons
ENST00000397732 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001529914 | 12484655 | 12484816 |
| ENSE00001893054 | 12461184 | 12465733 |
| ENSE00003596659 | 12466724 | 12466850 |
| ENSE00003682762 | 12466462 | 12466519 |
Expression profiles
Bgee: expression breadth ubiquitous, 171 present calls, max score 86.97.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.0497 / max 97.5973, expressed in 1313 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179312 | 4.6024 | 1289 |
| 179311 | 0.3602 | 170 |
| 179313 | 0.0871 | 54 |
Top tissues by expression
220 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.97 | gold quality |
| right testis | UBERON:0004534 | 83.37 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.09 | gold quality |
| left testis | UBERON:0004533 | 82.81 | gold quality |
| testis | UBERON:0000473 | 80.12 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.85 | gold quality |
| ventricular zone | UBERON:0003053 | 75.41 | gold quality |
| sperm | CL:0000019 | 75.16 | gold quality |
| right uterine tube | UBERON:0001302 | 72.63 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.78 | gold quality |
| oocyte | CL:0000023 | 70.64 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 70.25 | gold quality |
| cerebellar cortex | UBERON:0002129 | 70.21 | gold quality |
| cortical plate | UBERON:0005343 | 70.11 | gold quality |
| vena cava | UBERON:0004087 | 70.10 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 70.01 | gold quality |
| cerebellum | UBERON:0002037 | 69.32 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 69.11 | gold quality |
| muscle tissue | UBERON:0002385 | 69.09 | gold quality |
| calcaneal tendon | UBERON:0003701 | 68.71 | gold quality |
| adrenal tissue | UBERON:0018303 | 68.19 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 67.73 | gold quality |
| left ovary | UBERON:0002119 | 67.61 | gold quality |
| nucleus accumbens | UBERON:0001882 | 67.22 | gold quality |
| right ovary | UBERON:0002118 | 67.10 | gold quality |
| biceps brachii | UBERON:0001507 | 66.89 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 66.63 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 66.18 | gold quality |
| body of uterus | UBERON:0009853 | 65.68 | gold quality |
| apex of heart | UBERON:0002098 | 65.53 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.04 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
111 targeting ZNF709, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| rattus_norvegicus | Znf709l | ENSRNOG00000069976 |
Paralogs (15): ZNF14 (ENSG00000105708), ZNF57 (ENSG00000171970), ZNF791 (ENSG00000173875), ZNF443 (ENSG00000180855), ZNF101 (ENSG00000181896), ZNF563 (ENSG00000188868), ZNF799 (ENSG00000196466), ZNF700 (ENSG00000196757), ZNF441 (ENSG00000197044), ZNF433 (ENSG00000197647), ZNF44 (ENSG00000197857), ZNF823 (ENSG00000197933), ZNF442 (ENSG00000198342), ZNF844 (ENSG00000223547), ZNF878 (ENSG00000257446)
Protein
Protein identifiers
Zinc finger protein 709 — Q8N972 (reviewed: Q8N972)
All UniProt accessions (2): Q8N972, H7C129
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_689814* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (21 total): zinc finger region 19, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N972-F1 | 80.37 | 0.31 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 41 (showing top):
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, BARX1_TARGET_GENES, PCGF1_TARGET_GENES, SOX3_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR651_3P, MIR3121_3P, MIR7159_5P, MIR548AT_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
180 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF709 | PCBP4 | P57723 | 407 |
| ZNF709 | DENND4B | O75064 | 392 |
| ZNF709 | PRTFDC1 | Q9NRG1 | 388 |
| ZNF709 | KBTBD6 | Q86V97 | 348 |
| ZNF709 | PODXL2 | Q9NZ53 | 300 |
| ZNF709 | RABL6 | Q3YEC7 | 297 |
| ZNF709 | HELB | Q8NG08 | 296 |
| ZNF709 | DDX52 | Q9Y2R4 | 279 |
| ZNF709 | A0A0A6YYI9 | A0A0A6YYI9 | 255 |
| ZNF709 | ACTMAP | Q5BKX5 | 254 |
| ZNF709 | GTF2IRD1 | Q9UHL9 | 246 |
| ZNF709 | JPH3 | Q8WXH2 | 241 |
| ZNF709 | NOB1 | Q9ULX3 | 234 |
| ZNF709 | ZNF414 | Q96IQ9 | 231 |
| ZNF709 | RBM14 | Q96PK6 | 229 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EN1 | NFIB | psi-mi:“MI:2364”(proximity) | 0.470 |
| ECE1 | ZNF709 | psi-mi:“MI:0915”(physical association) | 0.370 |
| S100B | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| MRFAP1L1 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| PTX3 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| OR52B2 | PCCA | psi-mi:“MI:0914”(association) | 0.350 |
| KAZALD1 | ZNF865 | psi-mi:“MI:0914”(association) | 0.350 |
| GATA3 | BCL9 | psi-mi:“MI:2364”(proximity) | 0.270 |
| MYB | KMT2D | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (12): ZNF709 (Affinity Capture-MS), ZNF709 (Affinity Capture-MS), ZNF709 (Affinity Capture-MS), ZNF709 (Affinity Capture-MS), ZNF709 (Affinity Capture-MS), ZNF709 (Affinity Capture-MS), ZNF709 (Affinity Capture-MS), ZNF709 (Affinity Capture-MS), ZNF709 (Proximity Label-MS), ZNF709 (Proximity Label-MS), ZNF709 (Proximity Label-MS), ZNF709 (Affinity Capture-RNA)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 51 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1156 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:12466861:CCACA:C | acceptor_gain | 1.0000 |
| 19:12466862:CACA:C | acceptor_gain | 1.0000 |
| 19:12466865:A:C | acceptor_gain | 1.0000 |
| 19:12465731:CTT:C | acceptor_gain | 0.9900 |
| 19:12465732:TT:T | acceptor_gain | 0.9900 |
| 19:12465734:C:CC | acceptor_gain | 0.9900 |
| 19:12466457:CTCA:C | donor_loss | 0.9900 |
| 19:12466458:TCACC:T | donor_loss | 0.9900 |
| 19:12466459:CAC:C | donor_loss | 0.9900 |
| 19:12466459:CACC:C | donor_loss | 0.9900 |
| 19:12466460:A:C | donor_loss | 0.9900 |
| 19:12466460:A:T | donor_loss | 0.9900 |
| 19:12466461:C:CA | donor_loss | 0.9900 |
| 19:12466718:TCTTA:T | donor_loss | 0.9900 |
| 19:12466719:CTTAC:C | donor_loss | 0.9900 |
| 19:12466720:TTAC:T | donor_loss | 0.9900 |
| 19:12466720:TTACC:T | donor_loss | 0.9900 |
| 19:12466721:T:TG | donor_loss | 0.9900 |
| 19:12466722:A:AG | donor_loss | 0.9900 |
| 19:12466722:A:C | donor_loss | 0.9900 |
| 19:12466723:C:A | donor_loss | 0.9900 |
| 19:12466723:C:G | donor_loss | 0.9900 |
| 19:12466862:C:T | acceptor_gain | 0.9900 |
| 19:12484651:TTA:T | donor_loss | 0.9900 |
| 19:12484652:TA:T | donor_loss | 0.9900 |
| 19:12484653:A:AC | donor_gain | 0.9900 |
| 19:12484653:A:AG | donor_loss | 0.9900 |
| 19:12484653:AC:A | donor_gain | 0.9900 |
| 19:12484654:C:CG | donor_gain | 0.9900 |
| 19:12484654:C:CT | donor_loss | 0.9900 |
AlphaMissense
4321 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:12464383:G:C | F513L | 0.994 |
| 19:12464383:G:T | F513L | 0.994 |
| 19:12464385:A:G | F513L | 0.994 |
| 19:12464551:G:C | F457L | 0.993 |
| 19:12464551:G:T | F457L | 0.993 |
| 19:12464553:A:G | F457L | 0.993 |
| 19:12465139:G:C | F261L | 0.993 |
| 19:12465139:G:T | F261L | 0.993 |
| 19:12465141:A:G | F261L | 0.993 |
| 19:12464467:A:C | F485L | 0.992 |
| 19:12464467:A:T | F485L | 0.992 |
| 19:12464469:A:G | F485L | 0.992 |
| 19:12464299:A:C | F541L | 0.991 |
| 19:12464299:A:T | F541L | 0.991 |
| 19:12464301:A:G | F541L | 0.991 |
| 19:12464215:G:C | F569L | 0.990 |
| 19:12464215:G:T | F569L | 0.990 |
| 19:12464217:A:G | F569L | 0.990 |
| 19:12464635:G:C | F429L | 0.990 |
| 19:12464635:G:T | F429L | 0.990 |
| 19:12464637:A:G | F429L | 0.990 |
| 19:12465391:G:C | F177L | 0.989 |
| 19:12465391:G:T | F177L | 0.989 |
| 19:12465393:A:G | F177L | 0.989 |
| 19:12464131:G:C | F597L | 0.988 |
| 19:12464131:G:T | F597L | 0.988 |
| 19:12464133:A:G | F597L | 0.988 |
| 19:12464803:A:C | F373L | 0.988 |
| 19:12464803:A:T | F373L | 0.988 |
| 19:12464805:A:G | F373L | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000089549 (19:12468166 C>G), RS1000125533 (19:12461619 G>T), RS1000145934 (19:12472928 C>T), RS1000279050 (19:12466196 C>T), RS1000339841 (19:12480540 G>A), RS1000366507 (19:12473189 C>T), RS1000637374 (19:12467314 A>AT), RS1000795697 (19:12465881 G>A), RS1000855150 (19:12470942 A>G), RS1001002988 (19:12486435 A>G,T), RS1001136633 (19:12486235 G>A,C), RS1001153632 (19:12473397 T>C), RS1001345943 (19:12460929 CAT>C), RS1001528006 (19:12474656 C>T), RS1001563562 (19:12486542 GAAAAA>G,GAAAA,GAAAAAA)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, affects expression | 4 |
| aristolochic acid I | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| methyleugenol | increases expression | 1 |
| propionaldehyde | increases expression | 1 |
| trichostatin A | decreases expression | 1 |
| pentabromodiphenyl ether | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.